Data gathered: November 4
Alternative Data for Medpace
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 631 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 258,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | 41 | Sign up | Sign up | Sign up |
| App Downloads | 1 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 5 | Sign up | Sign up | Sign up |
| Facebook Followers | 5,034 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,209 | Sign up | Sign up | Sign up |
| Twitter Mentions | 8 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 736 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 48 | Sign up | Sign up | Sign up |
| Linkedin Employees | 5,744 | Sign up | Sign up | Sign up |
About Medpace
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
| Price | $317.96 |
| Target Price | Sign up |
| Volume | 195,450 |
| Market Cap | $9.93B |
| Year Range | $314.22 - $457.29 |
| Dividend Yield | 0% |
| PE Ratio | 28.01 |
| Analyst Rating | 43% buy |
| Industry | Medical Devices |
In the news
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDPNovember 1 - Finnhub |
|
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities lawsNovember 1 - GlobeNewswire |
|
 |
Medpace: A Compelling Long-Term Opportunity Amid Short-Term Headwinds (Rating Upgrade)October 31 - SeekingAlpha |
 |
abrdn plc Sells 3,684 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)October 31 - ETF Daily News |
MEDP Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the FirmOctober 31 - Finnhub |
|
|
International Assets Investment Management LLC Has $19.17 Million Stake in Medpace Holdings, Inc. (NASDAQ:MEDP)October 30 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 528M | 416M | 112M | 88M | 106M | 2.750 |
| Q1 '24 | 511M | 400M | 111M | 103M | 104M | 3.200 |
| Q4 '23 | 497M | 405M | 92M | 78M | 88M | 2.460 |
| Q3 '23 | 492M | 401M | 91M | 71M | 85M | 2.220 |
| Q2 '23 | 461M | 377M | 84M | 61M | 79M | 1.930 |
Insider Transactions View All
| Kraft Robert O. filed to sell 520 shares at $390.7. August 26 '24 |
| Kraft Robert O. filed to sell 520 shares at $390.7. August 26 '24 |
| BURWIG SUSAN E filed to sell 7,500 shares at $401.2. June 7 '24 |
| Troendle August J. filed to sell 654,656 shares at $395.5. May 29 '24 |
| Troendle August J. filed to sell 660,351 shares at $395.2. May 29 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Jul 9, 24 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat |
Feb 15, 24 | Sell | $1K - $15K |
Read more about Medpace (MEDP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, app downloads, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Medpace?
The Market Cap of Medpace is $9.93B.
What is Medpace's PE Ratio?
As of today, Medpace's PE (Price to Earnings) ratio is 28.01.
What is the current stock price of Medpace?
Currently, the price of one share of Medpace stock is $317.96.
How can I analyze the MEDP stock price chart for investment decisions?
The MEDP stock price chart above provides a comprehensive visual representation of Medpace's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Medpace shares. Our platform offers an up-to-date MEDP stock price chart, along with technical data analysis and alternative data insights.
Does MEDP offer dividends to its shareholders?
As of our latest update, Medpace (MEDP) does not offer dividends to its shareholders. Investors interested in Medpace should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Medpace?
Some of the similar stocks of Medpace are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.